PCTs fight for local decision making on controversial drugs

By Helen Crump2008-08-21T09:00:00

Primary care trusts must retain their right to decide whether patients receive controversial drugs in exceptional circumstances, PCT leaders have warned.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters

to HSJ

Already a subscriber? Sign into your account here